NK
Neil Kumar sold $4.3M of BBIO stock
Neil Kumar, Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO), sold 54,980 shares of BBIO stock worth $4.3M, per an SEC Form 4 filed Nov 20, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 18, 2026, 2 days before it was made public.
BBIO has moved +0.2% since the trade date, from $78.01 to $78.18 (Nov 19, 2026 close).
- Traded
- Nov 18, 2026
- Disclosed
- Nov 20, 2026
- Filing delay
- 2 days
- Price since
- +0.2%
- Role
- Chief Executive Officer
- Source
- SEC Form 4